David T. Hickman

1.2k total citations
28 papers, 884 citations indexed

About

David T. Hickman is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, David T. Hickman has authored 28 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in David T. Hickman's work include Alzheimer's disease research and treatments (12 papers), DNA and Nucleic Acid Chemistry (8 papers) and Chemical Synthesis and Analysis (6 papers). David T. Hickman is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), DNA and Nucleic Acid Chemistry (8 papers) and Chemical Synthesis and Analysis (6 papers). David T. Hickman collaborates with scholars based in Switzerland, United Kingdom and United States. David T. Hickman's co-authors include Andrea Pfeifer, Andreas Muhs, Maria Pihlgren, María Pilar López-Deber, Nampally Sreenivasachary, Nathalie Chuard, Fred Van Leuven, Jason Micklefield, Valérie Gafner and Natàlia Crespo‐Biel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

David T. Hickman

27 papers receiving 866 citations

Peers

David T. Hickman
Luke Rajah United Kingdom
W.S. Wade United States
Alexander J. Dear United Kingdom
David T. Hickman
Citations per year, relative to David T. Hickman David T. Hickman (= 1×) peers Therése Klingstedt

Countries citing papers authored by David T. Hickman

Since Specialization
Citations

This map shows the geographic impact of David T. Hickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Hickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Hickman more than expected).

Fields of papers citing papers by David T. Hickman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Hickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Hickman. The network helps show where David T. Hickman may publish in the future.

Co-authorship network of co-authors of David T. Hickman

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Hickman. A scholar is included among the top collaborators of David T. Hickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Hickman. David T. Hickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core. Bioorganic & Medicinal Chemistry. 52. 116528–116528. 7 indexed citations
2.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer’s Disease and Other Tauopathies. Journal of Medicinal Chemistry. 64(17). 12808–12830. 13 indexed citations
3.
Gabellieri, Emanuele, Francesca Capotosti, Jérôme Molette, et al.. (2020). Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies. European Journal of Medicinal Chemistry. 204. 112615–112615. 6 indexed citations
4.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2019). Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2178–2189. 134 indexed citations
5.
Sreenivasachary, Nampally, Heiko Kroth, Yvan Varisco, et al.. (2017). Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 27(6). 1405–1411. 22 indexed citations
6.
Theunis, Clara, Oskar Adolfsson, Natàlia Crespo‐Biel, et al.. (2016). Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope. Journal of Alzheimer s Disease. 56(2). 585–599. 11 indexed citations
7.
Hickman, David T., et al.. (2014). Engineering Amyloid-Like Assemblies from Unstructured Peptides via Site-Specific Lipid Conjugation. PLoS ONE. 9(9). e105641–e105641. 8 indexed citations
8.
Hickman, David T., et al.. (2014). Binding Affinity Measurement of Antibodies from Crude Hybridoma Samples by SPR. BIO-PROTOCOL. 4(21). 2 indexed citations
9.
Koers, Eline J., María Pilar López-Deber, Markus Weingarth, et al.. (2013). Dynamic Nuclear Polarization NMR Spectroscopy: Revealing Multiple Conformations in Lipid‐Anchored Peptide Vaccines. Angewandte Chemie International Edition. 52(41). 10905–10908. 33 indexed citations
10.
Theunis, Clara, Natàlia Crespo‐Biel, Valérie Gafner, et al.. (2013). Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy. PLoS ONE. 8(8). e72301–e72301. 196 indexed citations
11.
Pihlgren, Maria, Rime Madani, Valérie Giriens, et al.. (2012). TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell–independent isotype switch in mice. Blood. 121(1). 85–94. 37 indexed citations
12.
Hickman, David T. & T. Edwin Chow. (2012). Development of a Composite Model of Quality of Life: A Case Study in Austin, Texas. GIScience & Remote Sensing. 49(6). 802–821. 3 indexed citations
13.
Hickman, David T., María Pilar López-Deber, Deepak Nand, et al.. (2011). Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases. Journal of Biological Chemistry. 286(16). 13966–13976. 66 indexed citations
14.
Pihlgren, Maria, Rime Madani, David T. Hickman, et al.. (2009). P3‐281: The safety profile of ACI‐24, an oligo‐specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model. Alzheimer s & Dementia. 5(4S_Part_14). 3 indexed citations
15.
Gatouillat, Grégory, et al.. (2007). Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells. Cancer Letters. 257(2). 165–171. 13 indexed citations
16.
Muhs, Andreas, David T. Hickman, Maria Pihlgren, et al.. (2007). Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice. Proceedings of the National Academy of Sciences. 104(23). 9810–9815. 140 indexed citations
17.
Sreenivasachary, Nampally, David T. Hickman, Dominique Sarazin, & Jean‐Maríe Lehn. (2006). DyNAs: Constitutional Dynamic Nucleic Acid Analogues. Chemistry - A European Journal. 12(33). 8581–8588. 49 indexed citations
20.
Hickman, David T., P. M. King, James M. Slater, Matthew A. Cooper, & Jason Micklefield. (2001). KINETICALLY SELECTIVE BINDING OF SINGLE STRANDED RNA OVER DNA BY A PYRROLIDINE-AMIDE OLIGONUCLEOTIDE MIMIC (POM). Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1169–1172. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026